KeyCorp Cuts Health Catalyst (NASDAQ:HCAT) Price Target to $10.00

Health Catalyst (NASDAQ:HCAT – Free Report) had its target price lowered by KeyCorp from $12.00 to $10.00 in a research report released on Monday morning, Benzinga reports. The firm currently has an overweight rating on the stock. A number of other research firms have also weighed in on HCAT. Guggenheim upgraded shares of Health Catalyst […]

Related Keywords

United States ,Linda Llewelyn ,Canaccord Genuity Group ,Keycorp ,Nasdaq ,News Ratings For Health Catalyst Daily ,Pricet Rowe Associates Inc ,Hedge Funds Weigh In On Health Catalyst ,Vident Advisory ,Capital Partners ,Health Catalyst Inc ,Nuveen Asset Management ,Health Catalyst Stock Down ,Health Catalyst Company Profile ,Health Catalyst ,Barclays ,Jpmorgan Chase Co ,Analyst Recommendations For Health Catalyst ,Barclays Plc ,Free Report ,Genuity Group ,Moderate Buy ,Catalyst Stock Down ,Asset Management ,Get Free Report ,Health Catalyst Daily ,Nasdaq Hcat ,Thcat ,Medical ,Lower Price Target ,